Biological
GREINER BIO-ONE CUSTOMER MAGAZINE
Being strong together
Thank you for taking the time to read this, the fourth edition of our biological customer magazine and I hope that you will enjoy the exciting contents and gain some insights into the subjects that have kept us busy in 2020: the new coronavirus (Sars-CoV-2) and sustainability in the field of medical technology and life science.
In the first part of our magazine, we provide you with an insight into the antibody test procedure and indicate the stages of this where Greiner Bio-One products can also play a decisive role. We have also been able to launch an important new product during the crisis: The virus stabilization tube. We interview Moritz Wiesbauer, Team Leader Physical Testing and Change Control at Greiner Bio-One, who answers questions on development and what the company can learn from the crisis.
“Within three weeks of the initial meeting, we were already able to make the first serially producted products available to an American customer. After just three weeks more, we were able to offer the current tube on the market and deliver the first products to our customers.”
“All our products include our automatic (passive) safety mechanism, which requires no additional action by the user. We produce reliable, high quality, and cost-effective products for safe and successful catheter insertion. We take great pride in our production process, which has been honed to ensure consistent insertion parameters. ”
Blood. A priceless good
Did you know that just a few drops of blood are enough to perform a variety of analyses? Our current edition of biological therefore focusses on the simplest way of sampling: capillary blood collection. Learn what to pay attention to and how to successfully obtain a high-quality sample. Especially for this reason, we visited the very smallest of our patients: At the hospital's neonatal ward, where our MiniCollect® capillary blood collection system is used for sampling in children and neonates.
Since capillary blood is not suitable for all tests and some analyses require larger blood volumes, doctors and nurses sometimes need help to evaluate the most suitable veins – can the VeinViewer® product range provide a solution? Claire Wiesner and Andreas Mayr have answered interesting questions about a device that will save you a long search.
“The device uses harmless near infra-red (NIR), which is shone onto the skin. The haemoglobin in the blood absorbs the light and is reflected by the surrounding tissue. This information is processed by the VeinViewer® device, and is converted into an image which is then projected directly onto the skin in real time as a digital image by the LED light source.”
The dark side of sweetness
It took us a while to find a suitable name for our new publication, but we reached a decision in the end. 'biological' (the name) will do so much more than just tie in with our company's name. We have had a long time to build up extensive subject area knowledge, with over 50 years of experience as your partner in the field of biology and medicine. From now on, we would like to share this knowledge with you in our customer magazine.
biological will provide you with the latest findings on current topics and information about relevant innovative product developments – content designed specifically to appeal to you as a medical professional, laboratory researcher or academic. It was also important to include tips on how to get the best out of our products in the magazine.
The first edition of our new magazine will give you advice, information and tips for diabetes prevention and the megatrend that is E-health. A great deal of effort has gone into it so we hope you like the results!
“The GDM guidelines recommend using only collection tubes which meet preanalytical requirements regarding glycolysis inhibition when sending samples.”
We would like to direct you to the correct site for your country.